The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1981) · PubMed · Cited by 1,459
Expression of Multidrug Resistance Gene in Human Cancers
Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., et al. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.2.116 · Cited by 1,290
Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
Chaudhary, P. M., & Roninson, I. B. (1991) · Cell · doi:10.1016/0092-8674(91)90141-k · Cited by 934
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
Miyashita, T., & Reed, J. (1993) · Blood · doi:10.1182/blood.v81.1.151.151 · Cited by 882
Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene
Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C. T. M., Otter, M., Scheffer, G. L., Scheper, R. J., Borst, P., & Elferink, R. P. J. O. (1996) · Science · doi:10.1126/science.271.5252.1126 · Cited by 822
Dalton, W. S., Grogan, T. M., Meltzer, P. S., Scheper, R. J., Durie, B. G., Taylor, C. W., Miller, T. P., & Salmon, S. E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.4.415 · Cited by 556
Hyafil, F., Pauwels-Vergely, C., Vignaud, P. D., & Grand‐Perret, T. (1993) · PubMed · Cited by 525
Scheper, R. J., Broxterman, H. J., Scheffer, G. L., Kaaijk, P., Dalton, W. S., van Heijningen, T. H. M., van Kalken, C. K., Slovak, M. L., de Vries, E. G. E., & van der Valk, P. (1993) · PubMed · Cited by 493
Campos, L., Guyotat, D., Archimbaud, E., Calmard-Oriol, P., Tsuruo, T., Troncy, J., Treille, D., & Fiere, D. (1992) · Blood · doi:10.1182/blood.v79.2.473.473 · Cited by 487
Miyashita, T., & Reed, J. C. (1992) · PubMed · Cited by 475
Chan, H. S., Thorner, P. S., Haddad, G., & Ling, V (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.4.689 · Cited by 451
P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma
Chan, H. S. L., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H., & Ling, V. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252304 · Cited by 441
Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.
Ozols, R. F., Cunnion, R. E., Klecker, R. W., Hamilton, T. C., Ostchega, Y., Parrillo, J. E., & Young, R. C. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.4.641 · Cited by 426
Marie, J., Zittoun, R., & Sikic, B. (1991) · Blood · doi:10.1182/blood.v78.3.586.586 · Cited by 394
Self-citationMiller, T. P., Grogan, T. M., Dalton, W. S., Spier, C. M., Scheper, R. J., & Salmon, S. E. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.1.17 · Cited by 384
Chaudhary, P., Mechetner, E., & Roninson, I. (1992) · Blood · doi:10.1182/blood.v80.11.2735.2735 · Cited by 379
Boesch, D., Gavériaux‐Ruff, C., Jachez, B., Pourtier, A., Bollinger, P., & Loor, F. (1991) · PubMed · Cited by 360
MDR1 Gene Expression and Treatment Outcome in Acute Myeloid Leukemia
Pirker, R., Wallner, J., Geissler, K., Linkesch, W., Haas, O. A., Bettelheim, P., Hopfner, M., Scherrer, R., Valent, P., Havelec, L., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.10.708 · Cited by 355
How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture.
Gottesman, M. M. (1993) · PubMed · Cited by 352
Drach, D., Zhao, S., Drach, J., Mahadevia, R., Gattringer, C., Huber, H., & Andreeff, M. (1992) · Blood · doi:10.1182/blood.v80.11.2729.2729 · Cited by 317
Modulation of multidrug-resistant multiple myeloma by cyclosporin
Sonneveld, P., Lowenberg, B., Durie, B. G. M., Lokhorst, H. M., Marie, J.-P., Zittoun, R., Solbu, G., Suciu, S., & Nooter, K. (1992) · The Lancet · doi:10.1016/0140-6736(92)92353-h · Cited by 316
Lum, B. L., Kaubisch, S., Yahanda, A. M., Adler, K. M., Jew, L., Ehsan, M. N., Brophy, N. A., Halsey, J., Gosland, M. P., & Sikic, B. I. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.10.1635 · Cited by 299
Self-citationMolecular and Cellular Biology of Multidrug Resistance in Tumor Cells
(1991) · Springer eBooks · doi:10.1007/978-1-4615-3794-6 · Cited by 276
P-glycoprotein in human sarcoma: evidence for multidrug resistance.
Gerlach, J. H., Bell, D. R., Karakousis, C., Slocum, H. K., Kartner, N., Rustum, Y. M., Ling, V, & Baker, R. M. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.9.1452 · Cited by 255
Arceci, R. (1993) · Blood · doi:10.1182/blood.v81.9.2215.2215 · Cited by 227
Chen, Y. N., Mickley, L. A., Schwartz, A. M., Acton, E. M., Hwang, J. L., & Fojo, A. T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38781-2 · Cited by 221
Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.
Yahanda, A. M., Alder, K. M., Fisher, G. A., Brophy, N. A., Halsey, J., Hardy, R. I., Gosland, M. P., Lum, B. L., & Sikic, B. I. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.10.1624 · Cited by 214
Self-citationMultidrug resistance and the role of P-glycoprotein knockout mice
Schinkel, A. H., Mol, C. A. A. M., Wagenaar, E., van Deemter, L., Smit, J. J. M., & Borst, P. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00130-b · Cited by 199
Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.
Bartlett, N. L., Lum, B. L., Fisher, G. A., Brophy, N. A., Ehsan, M. N., Halsey, J., & Sikic, B. I. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.4.835 · Cited by 189
Self-citationP-glycoprotein and resistance to anticancer drugs
Ling, V. (1992) · Cancer · doi:10.1002/1097-0142(19920515)69:10<2603::aid-cncr2820691034>3.0.co;2-e · Cited by 180
Holzmayer, T. A., Hilsenbeck, S., Von Hoff, D. D., & Roninson, I. B. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.19.1486 · Cited by 178
Boote, D. J., Dennis, I. F., Twentyman, P. R., Osborne, R. J., Laburte, C., Hensel, S., Smyth, J. F., Brampton, M. H., & Bleehen, N. M. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.610 · Cited by 172
Clinical Studies with Modulators of Multidrug Resistance
Fisher, G. A., & Sikic, B. I. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30099-6 · Cited by 163
Self-citationThe effect of verapamil on the pharmacokinetics of adriamycin
Kerr, D. J., Graham, J., Cummings, J., Morrison, J. G., Thompson, G. G., Brodie, M. J., & Kaye, S. B. (1986) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00273394 · Cited by 145
Barrand, M. A., Rhodes, T., & Twentyman, P. R. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90397-x · Cited by 145
Lum, B. L., Fisher, G. A., Brophy, N. A., Yahanda, A. M., Adler, K. M., Kaubisch, S., Halsey, J., & Sikic, B. I. (1993) · Cancer · doi:10.1002/1097-0142(19931201)72:11+<3502::aid-cncr2820721618>3.0.co;2-n · Cited by 137
Self-citationPileri, S. A., Sabattini, E., Falini, B., Tazzari, P. L., Gherlinzoni, F., Michieli, M., Damiani, D., Zucchini, L., Gobbi, M., TSURUO, T., et al. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00003.x · Cited by 101
Keller, R. P., Altermatt, H. J., Donatsch, P., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510316 · Cited by 80
Arao, S., Suwa, H., Mandai, M., et al. (1994) · PubMed · Cited by 74
Beck, W. T. (1990) · Cancer Treatment Reviews · doi:10.1016/0305-7372(90)90011-4 · Cited by 71
Cited by
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment
Jang, K.-J., Mehr, A. P., Hamilton, G. A., McPartlin, L. A., Chung, S., Suh, K.-Y., & Ingber, D. E. (2013) · Integrative Biology · doi:10.1039/c3ib40049b · Cited by 849
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor
Lee, E. S., Na, K., & Bae, Y. H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.018 · Cited by 577
Role of transport proteins in drug absorption, distribution and excretion
Ayrton, A., & Morgan, P. (2001) · Xenobiotica · doi:10.1080/00498250110060969 · Cited by 421
Vaidyanathan, A., Sawers, L., Gannon, A.-L., Chakravarty, P., Scott, A. L., Bray, S. E., Ferguson, M. J., & Smith, G. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.203 · Cited by 364
Metadata
- Authors
- Sikic, B. I.
- Venue
- Cancer Chemotherapy and Pharmacology
- Published
- 1997-06-02
- Volume
- 40
- Issue
- 0
- Pages
- S13-S19
- ISSN
- 0344-5704 (ISSN-L)
- 1432-0843
- OpenAlex
- W1988234658
- Cited by
- 277
- References
- 45
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.